News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Annual General Meeting of the Shareholders of Anavex Life Sciences Corp.
June 5, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GENEVA, SWITZERLAND--(MARKET WIRE)--Jun 5, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTC BB:AVXL.OB - News) a biopharmaceutical company, announced the results of its recently held Annual General Meeting.
Twitter
LinkedIn
Facebook
Email
Print
Events
Europe
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Mergers & acquisitions
BIO 2026: Forget dual track—biopharma deals are more complex than ever
June 25, 2026
·
5 min read
·
Annalee Armstrong
Insights
The Golden Triangle and the gaps: Rethinking UK biotech
June 25, 2026
·
1 min read
·
Jennifer C. Smith-Parker